SCHEMBL20735095

SCHEMBL20735095

CCCCCC(CC)N1C(=O)c2cccc3c(-c4cccnc4)ccc(c23)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHPS P49366 4/20 0.44
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ CYP1B1 Q16678 2/20 0.40
▸ CNR2 P34972 2/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ MAPK1 P28482 3/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ CCR6 P51684 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ TLR8 Q9NR97 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20735194 0.98 DHPS (0.43) DHPSCYP11B1CYP11B2CYP1B1CNR2
SCHEMBL20735027 0.95 DHPS (0.41) DHPSCYP11B1CYP11B2CYP1B1CNR2
SCHEMBL20735209 0.88 CYP1B1 (0.39) DHPSCYP1B1MAPK1SMN1; SMN2MEN1
SCHEMBL23340439 0.88 DHPS (0.37) DHPSCYP11B1CYP11B2CYP1B1CNR2
SCHEMBL23340418 0.87 CYP1B1 (0.38) DHPSCYP1B1MAPK1SMN1; SMN2MEN1
SCHEMBL20735188 0.87 KMT2A (0.40) CYP1B1CNR2CNR1MAPK1SMN1; SMN2
SCHEMBL23340424 0.87 KMT2A (0.41) CYP1B1MAPK1MEN1POLBMAPT
SCHEMBL20735035 0.87 KMT2A (0.41) CYP1B1MAPK1MEN1POLBMAPT
SCHEMBL20735028 0.86 CYP1B1 (0.38) DHPSCYP1B1MAPK1SMN1; SMN2MEN1
SCHEMBL20735197 0.86 CYP1B1 (0.38) DHPSCYP1B1MAPK1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230209862-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 — — US disclosed
US-20230209862-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 — — US disclosed
US-11641754-B2 Organic light-emitting device and electronic apparatus including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-02 — — US disclosed
US-11641754-B2 Organic light-emitting device and electronic apparatus including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-02 — — US disclosed
EP-3442047-B1 ORGANIC LIGHT-EMITTING DISPLAY APPARATUS SAMSUNG DISPLAY CO LTD (KR) 2021-05-05 — — EP disclosed
US-10381596-B2 Organic light-emitting display apparatus with an encapsulation unit SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-13 — — US disclosed
US-20190051860-A1 ORGANIC LIGHT-EMITTING DISPLAY APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 — — US disclosed
US-20190051856-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190051860-A1 ORGANIC LIGHT-EMITTING DISPLAY APPARATUS ALDH1A1, AOX1, ALDH1A2 DHPS 2640/4885CYP11B1 3512/4885CYP11B2 3758/4885
US-10381596-B2 Organic light-emitting display apparatus with an encapsulation unit ALDH1A1, AOX1, AMY1A DHPS 2612/4885CYP11B1 3689/4885CYP11B2 3937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback